Inhibition of RIP1-dependent necrosis prevents adverse cardiac remodeling after myocardial ischemia–reperfusion in vivo

[1]  P. Doevendans,et al.  Targeting cell death in the reperfused heart: pharmacological approaches for cardioprotection. , 2013, International journal of cardiology.

[2]  P. Doevendans,et al.  Human versus porcine mesenchymal stromal cells: phenotype, differentiation potential, immunomodulation and cardiac improvement after transplantation , 2012, Journal of cellular and molecular medicine.

[3]  Ji Luo,et al.  Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis , 2012, Proceedings of the National Academy of Sciences.

[4]  Xiaodong Wang,et al.  Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase , 2012, Cell.

[5]  G. Kung,et al.  Programmed necrosis, not apoptosis, in the heart. , 2011, Circulation research.

[6]  L. Martin,et al.  Necrostatin Decreases Oxidative Damage, Inflammation, and Injury after Neonatal HI , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[7]  Xuehui Liu,et al.  Trimetazidine inhibits pressure overload-induced cardiac fibrosis through NADPH oxidase-ROS-CTGF pathway. , 2010, Cardiovascular research.

[8]  P. Vandenabeele,et al.  Molecular mechanisms of necroptosis: an ordered cellular explosion , 2010, Nature Reviews Molecular Cell Biology.

[9]  H. Bøtker,et al.  Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations , 2010, Basic Research in Cardiology.

[10]  G. Heusch,et al.  TNFalpha in atherosclerosis, myocardial ischemia/reperfusion and heart failure. , 2010, Pharmacology & therapeutics.

[11]  M. Goumans,et al.  MicroRNA-155 prevents necrotic cell death in human cardiomyocyte progenitor cells via targeting RIP1 , 2010, Journal of cellular and molecular medicine.

[12]  Akio Matsumoto,et al.  Biochemistry and physiology of mitochondrial ion channels involved in cardioprotection , 2010, FEBS letters.

[13]  M. Goumans,et al.  Active Wnt signaling in response to cardiac injury , 2010, Basic Research in Cardiology.

[14]  T. Vanden Berghe,et al.  The Role of the Kinases RIP1 and RIP3 in TNF-Induced Necrosis , 2010, Science Signaling.

[15]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2010 update: a report from the American Heart Association. , 2010, Circulation.

[16]  R. Kitsis,et al.  Cell death in the pathogenesis of heart disease: mechanisms and significance. , 2010, Annual review of physiology.

[17]  Xiangbin Xu,et al.  Direct relationship between levels of TNF-α expression and endothelial dysfunction in reperfusion injury , 2010, Basic Research in Cardiology.

[18]  G. Heusch,et al.  Inhibition of mitochondrial permeability transition pore opening: the holy grail of cardioprotection , 2010, Basic Research in Cardiology.

[19]  P. Doevendans,et al.  Myocardial Ischemia / Reperfusion Injury Is Mediated by Leukocytic Toll-Like Receptor-2 and Reduced by Systemic Administration of a Novel Anti – Toll-Like Receptor-2 Antibody , 2009 .

[20]  O. Carretero,et al.  Lack of Glutathione Peroxidase 1 Accelerates Cardiac-Specific Hypertrophy and Dysfunction in Angiotensin II Hypertension , 2010, Hypertension.

[21]  B. Gersh,et al.  Reperfusion Injury, Microvascular Dysfunction, and Cardioprotection: The “Dark Side” of Reperfusion , 2009, Circulation.

[22]  R. Erbel,et al.  Coronary microembolization: from bedside to bench and back to bedside. , 2009, Circulation.

[23]  L. Papucci,et al.  Role of NADPH oxidase in H9c2 cardiac muscle cells exposed to simulated ischaemia‐reperfusion , 2009, Journal of cellular and molecular medicine.

[24]  Na Zhang,et al.  RIP3, an Energy Metabolism Regulator That Switches TNF-Induced Cell Death from Apoptosis to Necrosis , 2009, Science.

[25]  Tao Wang,et al.  Receptor Interacting Protein Kinase-3 Determines Cellular Necrotic Response to TNF-α , 2009, Cell.

[26]  F. Chan,et al.  Phosphorylation-Driven Assembly of the RIP1-RIP3 Complex Regulates Programmed Necrosis and Virus-Induced Inflammation , 2009, Cell.

[27]  Yuyuan Han,et al.  Gαi1 and Gαi3 Are Required for Epidermal Growth Factor–Mediated Activation of the Akt-mTORC1 Pathway , 2009, Science Signaling.

[28]  D. Yellon,et al.  The mitochondrial permeability transition pore as a target for preconditioning and postconditioning , 2009, Basic Research in Cardiology.

[29]  C. Baines.  The mitochondrial permeability transition pore and ischemia-reperfusion injury , 2009, Basic Research in Cardiology.

[30]  E. Murphy,et al.  Cardioprotection and altered mitochondrial adenine nucleotide transport , 2009, Basic Research in Cardiology.

[31]  L. Boscá,et al.  Constitutive COX-2 activity in cardiomyocytes confers permanent cardioprotection Constitutive COX-2 expression and cardioprotection. , 2009, Journal of molecular and cellular cardiology.

[32]  G. Heusch,et al.  Cardioprotection: nitric oxide, protein kinases, and mitochondria. , 2008, Circulation.

[33]  M. Moskowitz,et al.  Necrostatin-1 Reduces Histopathology and Improves Functional Outcome after Controlled Cortical Impact in Mice , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[34]  Alexei Degterev,et al.  Identification of RIP1 kinase as a specific cellular target of necrostatins. , 2008, Nature chemical biology.

[35]  You-Sun Kim,et al.  TNFα and reactive oxygen species in necrotic cell death , 2008, Cell Research.

[36]  Richard T. Lee,et al.  Targeted Deletion of Thioredoxin-Interacting Protein Regulates Cardiac Dysfunction in Response to Pressure Overload , 2007, Circulation research.

[37]  M. Mocanu,et al.  The Cardioprotective Effect of Necrostatin Requires the Cyclophilin-D Component of the Mitochondrial Permeability Transition Pore , 2007, Cardiovascular Drugs and Therapy.

[38]  R. Bolli,et al.  Cardioprotection Afforded by Inducible Nitric Oxide Synthase Gene Therapy Is Mediated by Cyclooxygenase-2 via a Nuclear Factor-&kgr;B-Dependent Pathway , 2007, Circulation.

[39]  D. Yellon,et al.  Myocardial reperfusion injury. , 2007, The New England journal of medicine.

[40]  D. Yellon,et al.  Necrostatin: A Potentially Novel Cardioprotective Agent? , 2007, Cardiovascular Drugs and Therapy.

[41]  T. Kodama,et al.  Gab family proteins are essential for postnatal maintenance of cardiac function via neuregulin-1/ErbB signaling. , 2007, The Journal of clinical investigation.

[42]  S. Sollott,et al.  Mitochondrial ROS-induced ROS release: an update and review. , 2006, Biochimica et biophysica acta.

[43]  H. Osada,et al.  Inhibition of ADP/ATP Exchange in Receptor-Interacting Protein-Mediated Necrosis , 2006, Molecular and Cellular Biology.

[44]  H. Krum,et al.  Catalytic Degradation of Vitamin D Up-regulated Protein 1 mRNA Enhances Cardiomyocyte Survival and Prevents Left Ventricular Remodeling after Myocardial Ischemia* , 2005, Journal of Biological Chemistry.

[45]  Alexei Degterev,et al.  Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury , 2005, Nature chemical biology.

[46]  J. Vinten-johansen.  Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. , 2004, Cardiovascular research.

[47]  J. Turrens,et al.  Mitochondrial formation of reactive oxygen species , 2003, The Journal of physiology.

[48]  R. Gottlieb.  Mitochondrial signaling in apoptosis: Mitochondrial daggers to the breaking heart , 2003, Basic Research in Cardiology.

[49]  A. Shah,et al.  Increased myocardial NADPH oxidase activity in human heart failure. , 2003, Journal of the American College of Cardiology.

[50]  D. Yellon,et al.  The mitochondrial permeability transition pore: its fundamental role in mediating cell death during ischaemia and reperfusion. , 2003, Journal of molecular and cellular cardiology.

[51]  R. Jackson,et al.  Reactive species mechanisms of cellular hypoxia-reoxygenation injury. , 2002, American journal of physiology. Cell physiology.

[52]  塩見 哲也.  Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice , 2005 .